Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Epidemiol Infect ; 145(15): 3219-3225, 2017 11.
Artigo em Inglês | MEDLINE | ID: mdl-28903791

RESUMO

An outbreak of mumps within a student population in Scotland was investigated to assess the effect of previous vaccination on infection and clinical presentation, and any genotypic variation. Of the 341 cases, 79% were aged 18-24. Vaccination status was available for 278 cases of whom 84% had received at least one dose of mumps containing vaccine and 62% had received two. The complication rate was 5·3% (mainly orchitis), and 1·2% were admitted to hospital. Genetic sequencing of mumps virus isolated from cases across Scotland classified 97% of the samples as genotype G. Two distinct clusters of genotype G were identified, one circulating before the outbreak and the other thereafter, suggesting the virus that caused this outbreak was genetically different from the previously circulating virus. Whilst the poor vaccine effectiveness we found may be due to waning immunity over time, a contributing factor may be that the current mumps vaccine is less effective against some genotypes. Although the general benefits of the measles-mumps-rubella (MMR) vaccine should continue to be promoted, there may be value in reassessing the UK vaccination schedule and the current mumps component of the MMR vaccine.


Assuntos
Surtos de Doenças/estatística & dados numéricos , Vacina contra Caxumba/uso terapêutico , Vírus da Caxumba/genética , Caxumba/epidemiologia , Estudantes/estatística & dados numéricos , Adolescente , Surtos de Doenças/prevenção & controle , Feminino , Variação Genética/genética , Humanos , Masculino , Caxumba/imunologia , Caxumba/prevenção & controle , Caxumba/virologia , Vacina contra Caxumba/imunologia , Vírus da Caxumba/imunologia , Reação em Cadeia da Polimerase em Tempo Real , Escócia/epidemiologia , Adulto Jovem
2.
Intern Med J ; 46(4): 452-7, 2016 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-26765074

RESUMO

BACKGROUND: Human papillomavirus (HPV) vaccines are currently utilised globally in national immunisation programmes. While evidence from clinical trials and epidemiological studies suggest that the HPV vaccines are both effective and safe, concerns about the safety of the vaccine and scientifically unproven associations with severe adverse events following immunisation have led to dramatic decreases in vaccine uptake in Japan and acceptance issues in other countries. AIM: In Scotland, we utilised hospital admissions data to assess the impact of the HPV immunisation programme on the incidence of 60 diagnoses between 2004 and 2014 in both girls and boys; with boys acting as a comparator group. METHODS: Tabular and graphical outputs of the number of admissions, the incidence and the incidence ratio of 59 diagnoses were created to assess trends before and after the introduction of the HPV vaccine. Data linkage was utilised to investigate further the increase in Bell palsy diagnoses. RESULTS: Fifty-four diagnoses showed no change in incidence following the introduction of the national immunisation programme, and while small increases in incidence were observed for Bell palsy, coeliac disease, ovarian dysfunction, juvenile onset of type 1 diabetes, demyelinating disease and juvenile rheumatoid arthritis, none was statistically significant. CONCLUSIONS: Consistent with previous evidence, we present disaggregate data that reiterate the safety of both HPV vaccines.


Assuntos
Sistemas de Notificação de Reações Adversas a Medicamentos/tendências , Programas de Imunização/tendências , Vacinas contra Papillomavirus/efeitos adversos , Admissão do Paciente/tendências , Adolescente , Anemia Hemolítica/induzido quimicamente , Anemia Hemolítica/epidemiologia , Criança , Feminino , Humanos , Programas de Imunização/métodos , Masculino , Escócia/epidemiologia , Trombocitopenia/induzido quimicamente , Trombocitopenia/epidemiologia
3.
Neural Comput ; 23(8): 2000-31, 2011 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-21521041

RESUMO

An important class of psychological models of decision making assumes that evidence is accumulated by a diffusion process to a response criterion. These models have successfully accounted for reaction time (RT) distributions and choice probabilities from a wide variety of experimental tasks. An outstanding theoretical problem is how the integration process that underlies diffusive evidence accumulation can be realized neurally. Wang ( 2001 , 2002 ) has suggested that long timescale neural integration may be implemented by persistent activity in reverberation loops. We analyze a simple recurrent decision making architecture and show that it leads to a diffusive accumulation process. The process has the form of a time-inhomogeneous Ornstein-Uhlenbeck velocity process with linearly increasing drift and diffusion coefficients. The resulting model predicts RT distributions and choice probabilities that closely approximate those found in behavioral data.


Assuntos
Encéfalo/fisiologia , Tomada de Decisões/fisiologia , Modelos Neurológicos , Modelos Teóricos , Tempo de Reação/fisiologia , Algoritmos , Animais , Humanos
4.
J Med Microbiol ; 65(2): 142-146, 2016 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-26704297

RESUMO

The reported incidence of Legionnaires' disease caused by Legionella longbeachae has increased since 2008 in Scotland. While microbiological and epidemiological studies have identified exposure to growing media as a risk factor for infection, little is known about the differences regarding disease risk factors, clinical features and outcomes of infection with L. longbeachae when compared with L. pneumophila. A nested case-case study was performed comparing 12 L. longbeachae cases with 25 confirmed L. pneumophila cases. Fewer L. longbeachae infected patients reported being smokers [27% (95% CI 2-52%) vs. 68% (95% CI 50-86%), P = 0.034] but more L. longbeachae patients experienced breathlessness [67% (95% CI 40-94%) vs. 28% (95% CI 10-46%), P = 0.036]. Significantly more L. longbeachae-infected patients received treatment in intensive care [50% (95% CI 22-78%) vs. 12% (95% CI 0-25%), P = 0.036]. However, the differences in diagnostic methods between the two groups may have led to only the most severe cases of L. longbeachae being captured by the surveillance system. No differences were observed in any of the other pre-hospital symptoms assessed. Our results highlight the similarity of Legionnaires' disease caused by L. pneumophila and L. longbeachae, and reinforce the importance of diagnostic tools other than the urinary antigen assays for the detection of non-L. pneumophila species. Unfortunately, cases of community-acquired pneumonia caused by Legionella species will continue to be underdiagnosed unless routine testing criteria changes.


Assuntos
Legionella longbeachae/fisiologia , Legionella pneumophila/fisiologia , Doença dos Legionários/microbiologia , Idoso , Antibacterianos/administração & dosagem , Feminino , Humanos , Legionella longbeachae/efeitos dos fármacos , Legionella longbeachae/isolamento & purificação , Legionella pneumophila/efeitos dos fármacos , Legionella pneumophila/isolamento & purificação , Doença dos Legionários/diagnóstico , Doença dos Legionários/tratamento farmacológico , Doença dos Legionários/epidemiologia , Masculino , Pessoa de Meia-Idade , Saúde Pública , Escócia/epidemiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA